NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘cancer’

23 April 2015

Wellington, Redmile back $56m for cancer fighting company Jounce

lab-work-803087-m Venture capital investors Wellington Management Company, Redmile Group and Nextech Invest have backed a $56m Series B round for cancer immunotherapeutics developer Jounce Therapuetics.

24 March 2015

New VCs help anti-cancer treatment pioneer Rigontec push Series A to €14.25m

Dutch early stage investor Forbion Capital Partners and Danish peer Sunstone Capital have brought biopharma business Rigontec's Series A round to €14.25m through a second close.

4 February 2015

Lightspeed drives $50m Series C for cancer analysis company Guardant Health

life science test tube_sq Lightspeed Venture Partners has led a $50m Series C funding round for Guardant Health, which has a vision of transforming cancer into a manageable disease.

9 January 2015

NEA, Atlas among VC backers $35m Surface Oncology Series A

Opsona research lab Cancer immunotherapy business Surface Oncology has picked up $35m of Series A financing from a string of venture capital firms.

14 November 2014

Anti-cancer business Blueprint Medicines bags $50m VC-backed Series C

blueprint_real_estate_170sq A string of venture capital firms have backed a $50m Series C financing round for cancer treatment developer Blueprint Medicines.

30 September 2014

Montagu to make 2x return in €1bn Euromedic exit deal $

blue-first-aid-box-911384-m European major Montagu Private Equity will double its money selling its stake in pan-European medical services provider Euromedic International, AltAssets has learned.

26 September 2014

Vestar-backed 21st Century Oncology gets $325m CPPIB investment

21st century oncology Canadian pension giant CPPIB has invested $325m in Vestar Capital-backed cancer treatment centre network 21st Century Oncology Holdings.

29 August 2014

Leukemia & Lymphoma Society in $6.9m Series B for blood cancer specialist OncoPep

test-tubes-1-149744-m New and existing investors have laid down $6.9m Series B funding for blood cancer-fighting company OncoPep.

28 August 2014

RA Capital, Redmile in huge $55m Series C for cancer-fighting biotech business

cancer juno RA Capital Management and Redmile Group were among 11 new investors in a $55m Series C financing round for biotech company Bellicum Pharmaceuticals.

26 August 2014

Gimv exits Covagen after six years

covagen Investment firm Gimv has exited its portfolio company Covagen to an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson after more than six years.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015